Vlacho, Bogdan http://orcid.org/0000-0003-3768-8112
Bundó, Magdalena
Llussà, Judit
Real, Jordi
Mata-Cases, Manel
Cos, Xavier
Tundidor, Diana
Zaccardi, Francesco
Khunti, Kamlesh
Jude, Edward B.
Franch-Nadal, Josep http://orcid.org/0000-0002-5175-1555
Mauricio, Dídac http://orcid.org/0000-0002-2868-0250
Funding for this research was provided by:
8a Convocatòriad'Ajuts a projectes de InstitutCatalà de la Salut with SIDIAP (4R18/187-1 and file number SIDIAP-18/7)
Article History
Received: 11 April 2024
Accepted: 13 June 2024
First Online: 19 June 2024
Declarations
:
: The study involving human participants was reviewed and approved by Primary Health Care University Research Institute Jordi Gol (number 19/035-P). Written informed consent for participation was not required for this study following the national legislation and the institutional requirements.
: Not applicable.
: Manel Mata-Cases has received advisory and/or speaking fees from Astra-Zeneca, Bayer, Boehringer Ingelheim, GSK, Lilly, MSD, NOVARTIS, NovoNordisk, and Sanofi; he has received research grants to the institution from Astra-Zeneca, GSK, Lilly, MSD, Novartis, NovoNordisk, and Sanofi. Josep Franch-Nadal has received advisory and/or speaking fees from Astra-Zeneca, Ascensia, Boehringer Ingelheim, GSK, Lilly, MSD, Novartis, NovoNordisk, and Sanofi; he has received research grants to the institution from Astra-Zeneca, GSK, Lilly, MSD, Novartis, NovoNordisk, Sanofi, and Boehringer. Dídac Mauricio has received advisory and/or speaking fees from AB Biotics, Almirall, Amgen, Ferrer, Gilead, Lilly, Merck Sharp & Dohme, Menarini, Novo Nordisk and Sanofi. Prof. Mauricio is a co-author of this study and an Editorial Board member of the Cardiovascular diabetology journal. He was not involved in handling this manuscript during the submission and the review processes. Magdalena Bundó, Judit Llussà, have received advisory and speaking fees from MSD. Edward B Jude has received educational, sponsorship and speaker fees from Astra Zeneca, Bayer, Lilly, Menarini, Novonordisk and Sanofi. Xavier Cos has received speaker’s bureau and advisory board honoraria from AstraZeneca, Boehringer Ingelheim, Esteve, Lilly Diabetes, Novo Nordisk A/S, Roche, and Sanofi. Kamlesh Khunti KK has acted as a consultant, speaker or received grants for investigator-initiated studies for Astra Zeneca, Bayer, Novartis, Novo Nordisk, Sanofi-Aventis, Lilly and Merck Sharp & Dohme, Boehringer Ingelheim, Oramed Pharmaceuticals, Pfizer, Roche, Daiichi-Sankyo and Applied Therapeutics. Jordi Real, Diana Tundidor, Francesco Zaccardi and Bogdan Vlacho have no conflict of interest to declare.